Your browser doesn't support javascript.
loading
Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer.
Fountzilas, Elena; Kotoula, Vassiliki; Pentheroudakis, George; Manousou, Kyriaki; Polychronidou, Genovefa; Vrettou, Eleni; Poulios, Christos; Papadopoulou, Eirini; Raptou, Georgia; Pectasides, Eirini; Karayannopoulou, Georgia; Chrisafi, Sofia; Papakostas, Pavlos; Makatsoris, Thomas; Varthalitis, Ioannis; Psyrri, Amanda; Samantas, Epaminontas; Bobos, Mattheos; Christodoulou, Christos; Papadimitriou, Christos; Nasioulas, George; Pectasides, Dimitrios; Fountzilas, George.
Afiliação
  • Fountzilas E; Department of Investigational Cancer Therapeutics, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.
  • Kotoula V; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Pentheroudakis G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Manousou K; Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
  • Polychronidou G; Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece, Athens, Greece.
  • Vrettou E; Department of Medical Oncology, Papageorgiou Hospital, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Poulios C; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Papadopoulou E; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Raptou G; GeneKor Medical SA, Athens, Greece.
  • Pectasides E; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Karayannopoulou G; Department of Medicine, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Chrisafi S; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Papakostas P; Department of Pathology, Aristotle University of Thessaloniki, School of Health Sciences, Faculty of Medicine, Thessaloniki, Greece.
  • Makatsoris T; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Varthalitis I; Oncology Unit, Hippokration Hospital, Athens, Greece.
  • Psyrri A; Department of Medicine, Division of Oncology, University Hospital, University of Patras Medical School, Patras, Greece.
  • Samantas E; Oncology Department, General Hospital of Chania, Chania, Greece.
  • Bobos M; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Christodoulou C; Third Department of Medical Oncology, AgiiAnargiri Cancer Hospital, Athens, Greece.
  • Papadimitriou C; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Nasioulas G; Second Department of Medical Oncology, Metropolitan Hospital, Piraeus, Greece.
  • Pectasides D; Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Fountzilas G; GeneKor Medical SA, Athens, Greece.
ESMO Open ; 4(2): e000474, 2019.
Article em En | MEDLINE | ID: mdl-31231557

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article